Australia · Healthcare · AUD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average
Amounts in AUD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for NANOLLOSE LIMITED? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
| ROE | -359.84% | 458.09% | 107.5% | 86.85% | 79.91% | 77.25% |
|---|---|---|---|---|---|---|
| ROA | -190.76% | -320.45% | - | - | - | - |
| Total Assets | A$747.79K | A$130.47K | A$130.47K | A$130.47K | A$130.47K | A$130.47K |
| Net Income | -A$1,426.45K | -A$1,407.18K | -A$2,349.28K | -A$5,158.08K | -A$11,336.41K | -A$24,990.46K |
| Sector average | -A$3,880.45K | -A$2,145.08K | -A$11,910.51K |
| -A$30,010.60K |
| -A$55,285.83K |
| -A$84,977.09K |